Cargando…
Developments in (177)Lu-based radiopharmaceutical therapy and dosimetry
(177)Lu is a radioisotope that has become increasingly popular as a therapeutic agent for treating various conditions, including neuroendocrine tumors and metastatic prostate cancer. (177)Lu-tagged radioligands are molecules precisely designed to target and bind to specific receptors or proteins cha...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424930/ https://www.ncbi.nlm.nih.gov/pubmed/37583569 http://dx.doi.org/10.3389/fchem.2023.1218670 |